On June 30, 2016, transparency efforts around the world released numbers on financial interactions between industry and physicians. This article goes through recent releases in Germany and the United Kingdom, including analysis on where the money is coming from, and who it is going to.
Transparency of payments to healthcare providers and institutions is no longer just an “American thing.” Countries around the world have slowly started to adopt various transparency laws and regulations over the past few years. Here in America, we have the Physician Payments Sunshine Act (PPSA) 9 while much of Europe is subject to the transparency requirements under the European Federation of Pharmaceutical Industries and Associations, and UK transparency is set by the Association of the British Pharmaceutical Industry.
Read Full Article in the August 2016 Issue of Life Science Compliance Update
Why not just make the article available on your site?